NASDAQ:ZNTL | Income Statement | Zentalis Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$35.16M$44.39M-$44.39M-$42.15M$138,000.00-$42.29M-$0.59-$0.5971,326,00071,326,000
2026-03-31$28.72M$37.86M-$37.86M-$35.23M$120,000.00-$35.35M-$0.50-$0.5070,264,00070,264,000
2025-12-31$0.00$29.49M$37.39M-$37.39M-$34.77M$442,000.00-$35.22M-$0.49-$0.49-69,000-69,000
2025-09-30$0.00$22.95M$33.73M-$33.73M-$26.69M$0.00-$26.69M-$0.37-$0.3772,139,00072,139,000
2025-06-30$0.00$27.61M$36.06M-$36.06M-$26.87M$0.00-$26.87M-$0.37-$0.3771,992,00071,992,000
2025-03-31$0.00$27.25M$45.62M-$45.62M-$48.28M$0.00-$48.28M-$0.67-$0.6771,678,00071,678,000
2024-12-31$26.87M$32.97M$76.71M-$49.85M-$47.68M-$205,000.00-$47.47M-$0.66-$0.6663,00063,000
2024-09-30$0.00$36.82M$51.43M-$51.43M-$40.19M-$27,000.00-$40.16M-$0.56-$0.5671,111,00071,111,000
2024-06-30$0.00$48.39M$65.15M-$65.15M-$88.01M$266,000.00-$88.28M-$1.24-$1.2471,040,00071,040,000
2024-03-31$40.56M$49.59M$65.33M-$24.77M$10.18M$143,000.00$10.07M$0.14$0.1470,898,00071,192,000
2023-12-31$0.00$51.56M$67.92M-$67.92M-$77.09M-$135,000.00-$60.92M-$0.83-$0.831,808,0001,808,000
2023-09-30$0.00$46.77M$62.72M-$62.72M-$55.51M$31,000.00-$55.53M-$0.79-$0.7970,612,00070,612,000
2023-06-30$0.00$42.68M$103.92M-$103.92M-$99.47M-$605,000.00-$112.53M-$1.85-$1.8560,790,00060,790,000
2023-03-31$0.00$48.58M$64.95M-$64.95M-$60.84M$108,000.00-$63.22M-$1.07-$1.0759,277,00059,277,000
2022-12-31$40.62M$51.75M-$51.75M-$64.8M-$360,000.00-$54.97M-$0.92-$0.921,759,0001,759,000
2022-09-30$42.18M$54.19M-$54.19M-$52.29M-$159,000.00-$54.4M-$0.96-$0.9656,807,00056,807,000
2022-06-30$43.83M$63.46M-$63.46M-$63.04M$17,000.00-$68.36M-$1.34-$1.3451,117,00051,117,000
2022-03-31$46.11M$57.88M-$57.88M-$57.45M$33,000.00-$59.08M-$1.31-$1.3145,244,00045,244,000
2021-12-31$38.44M$48.19M-$48.19M-$49.94M$159,000.00-$50.06M-$1.13-$1.13770,000770,000
2021-09-30$54M$62.87M-$62.87M-$11.19M-$697,000.00-$4.19M-$0.09-$0.0944,609,00044,609,000
2021-06-30$44.77M$55.13M-$55.13M-$55.02M$45,000.00-$54.57M-$1.34-$1.3440,738,00040,738,000
2021-03-31$38.39M$50.35M-$50.35M-$50.25M$196,000.00-$49.9M-$1.24-$1.2440,359,00040,359,000
2020-12-31$29.52M$40.25M-$40.25M-$39.93M$426,000.00-$40.3M-$0.98-$0.983,970,0003,970,000
2020-09-30$24.67M$34.77M-$34.77M-$34.65M$18,000.00-$34.56M-$0.91-$0.9137,959,00037,959,000
2020-06-30$17.45M$27.38M-$27.38M-$27.29M$0.00-$26.86M-$0.78-$0.7834,353,00034,353,000
2020-03-31$13.26M$16.4M-$16.4M-$16.24M$0.00-$16.13M5,601,000
2019-12-31$11.87M$14.91M-$14.91M-$14.55M$0.00-$14.51M-4,000
2019-09-30$10.74M$12.58M-$12.58M-$12.57M$1,000.00-$12.34M5,601,000
2019-06-30$8.69M$10.64M-$10.64M-$10.59M$11,000.00-$10.47M5,601,000
2019-03-31$7.09M$8.72M-$8.72M-$8.66M$3,000.00-$8.34M5,594,000

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$0.00$107.3M$152.81M-$152.81M-$136.62M$442,000.00-$137.06M-$1.91-$1.9171,869,00071,869,000
2024-12-31$67.43M$167.77M$258.62M-$191.19M-$165.69M$177,000.00-$165.84M-$2.33-$2.3371,080,00071,080,000
2023-12-31$0.00$189.59M$299.51M-$299.51M-$292.91M-$601,000.00-$292.19M-$4.47-$4.4765,409,00065,409,000
2022-12-31$0.00$172.73M$227.29M-$227.29M-$237.58M-$469,000.00-$236.81M-$4.48-$4.4852,857,00052,857,000
2021-12-31$175.6M$216.54M-$216.54M-$166.39M-$297,000.00-$158.73M-$3.72-$3.7242,688,00042,688,000
2020-12-31$84.9M$118.79M-$118.79M-$118.1M$444,000.00-$117.84M-$4.19-$4.1928,113,00028,113,000
2019-12-31$38.39M$46.85M-$46.85M-$46.36M$15,000.00-$45.66M-$8.165,597,0005,597,000

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.